Lineage switching (LS) facilitates acute myeloid leukemia (AML) escaping CD19 targeted immunotherapy, but the underlying mechanism are not well understood. The authors here analyze patients’ single-cell mass cytometry and single-cell transcriptomics data, and identify an LS AML with the MDSC-like phenotype which is associated with LS in AML with KMT2A rearrangement.
- Takashi Mikami
- Itaru Kato
- Junko Takita
